Prognostic factors for glioblastoma multiforme: Development of a prognostic index

Acta Oncologica

Volumn 35, Issue SUPPL. 8, 1996, Pages 123-127

  Gundersen, Stein ^a   Lote, Knut ^a   Hannisdal, Einar ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BEHAVIOR; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

AGE FACTORS; BRAIN NEOPLASMS; DEXAMETHASONE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RANDOM ALLOCATION;

EID: 0030434057     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609098530     Document Type: Article

References (27)

1. Lote K, Gundersen S, Hannisdal E, et al. Prognosen ved primære svulster i sentralnervesystemet. Det Norske Radiumhospitals pasientmateriale 1980-1994. Tidsskr Nor Legeforen 1996; 11: 1320-4.
2. Kelly KA, Kirkwood JM, Kapp DS. Glioblastoma multiforme: pathology, natural history and treatment. Cancer Treat Rev 1984; 11: 1-26.
3. Anderson AP. Postoperative irradiation of glioblastomas. Results in a randomised series. Acta Radiol 1978; 17: 475-84.
4. Kristiansen K, Hagen S, Kollevold T, et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of post-operative irradiation and lack of potentiation of bleomycin on survival time. Cancer 1981; 47: 649-52.
5. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978; 49: 333-43.
6. Walker MD, Green SB, Byar DP, et al. Randomised comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Eng J Med 1980; 303: 1323-9.
7. Green SB, Byar DP, Walker MD, et al. Comparison of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 67: 121-32.
8. Fine HA, Dear KGB, Loeffler JS, et al. Meta-analysis of radiation therapy with and without chemotherapy in malignant gliomas in adults. Cancer 1993; 71: 2585-97.
9. Bloom HJG. Intracranial tumours: Response and resistance to therapeutic endeavours, 1970-1980. Int J Radiat Oncol Biol Phys 1982; 8: 1083-113.
10. Gaspar LE, Fisher BJ, Macdonald DR, et al. Malignant glioma-Timing of response to radiation therapy. Int J Radiat Oncol Biol Phys 1993; 25: 877-9.
11. Leibel SA, Sheline GE. Radiation therapy for brain tumors. J Neurosurg 1987; 66: 1-21.
12. Levin SA, Sheline GA, Gutin PH. Cancer of the central nervous system. In: DeVita VT, ed. Cancer. Principles and practice of oncology. Philadelphia: JB Lippincott; 1989: 1557-79.
13. Loeffler JS. Radiotherapy in managing malignant gliomas: Current role and future directions. Adv Oncol 1992; 8:14-20.
14. Nelson DF, Diener-West M, Horton J, et al. Combined modality approach to treatment of malignant gliomas-Reevaluation of RTOG 7401/ECOG 1374 with long-term follow up: A joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Mono 1988; 6: 279-84.
15. Bauman GS, Gaspar LE, Fisher BJ, et al. A prospective study of short course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994; 4: 835-9.
16. Hutton JL, Smith DF, Sandemann D, et al. Development of a prognostic index for primary supratentorial intracerebral tumours. J Neurol Neurosurg Psychiat 1992; 55: 271-4.
17. A report of the Medical Research Council Brain Tumour Working Party. Prognostic factors for high-grade malignant glioma: Development of a prognostic index. J Neuro-Oncol 1990; 9: 47-55.
18. International histologic classification of tumours No. 21. Histologic typing of tumours of the central nervous system. Geneva: WHO, 1979.
19. Peto R, Pike MC Armitage P, et al. Design and analysis of clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1-39.
20. Dixon WJ, Brown MB, Engelman L, et al. 'BMDP Statistical Software 1983'. Berkeley: University of California Press, 1983.
21. Watne K, Hannisdal E, Nome O, et al. Prognostic factors in high-grade malignant gliomas with reference to intra-arterial chemotherapy. Acta Oncol 1993; 32: 307-10.
22. Gehan EA, Walker MD. Prognostic factors for patients with brain tumors. NCI Mono 1977; 46: 189-95.
23. Byar DP, Green SB, Strike TA. Prognostic factors for malignant glioma. In: Walker MD, ed. Oncology of the nervous system. Boston: Martinus Nijhoff, 1983; 379-95.
24. Brisman R, Housepian EM, Chang C, et al. Adjuvant nitrosourea therapy for glioblastoma. Arch Neurol 1976; 33: 745-50.
25. Eyre HJ, Quagliana JM, Eltringham JR, et al. Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. J Neuro-Oncol 1983; 1: 171-7.
26. Chang CH, Horton J, Schoenfeld D, et al. Comparison of post-operative radiotherapy and combined post-operative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983; 52: 997-1007.
27. Smith DF, Hutton JL, Sandemann D, et al. The prognosis of primary incerebral tumours presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neurosurg Psychiatry 1991; 54: 915-20.